PFS
NVAX icon

Prospera Financial Services’s Novavax NVAX Stock Holding History

Prospera Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-164
Closed -$8K – 1353
2022
Q2 		$8K Hold
164
– – ﹤0.01% 1393
2022
Q1 		$12K Buy
+164
New +$14.6K ﹤0.01% 1957
2020
Q4 		– Sell
-164
Closed -$18K – 1265
2020
Q3 		$18K Buy
+164
New +$20K 0.01% 930

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Prospera Financial Services's NVAX Position: Q3 2022 in Review

Prospera Financial Services sold out of Novavax (NVAX) in Q3 2022, closing a stake of 164 shares — an estimated $8K sold.

Prospera Financial Services first reported a position in NVAX in Q3 2020 and held it in 3 quarters. The position peaked at $18K in Q3 2020. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Prospera Financial Services reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 164 Novavax shares in Q3 2022, an estimated $8K.
  • Prospera Financial Services first reported a position in Novavax in Q3 2020 and held it in 3 quarters.
  • Prospera Financial Services's Novavax position peaked at $18K in Q3 2020.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.